Luigi Mangione, the suspect accused in the 2024 murder of UnitedHealthcare CEO Brian Thompson, returned to federal court on Friday as the judge prepares to consider a series of legal motions from his defense team that could narrow or even dismiss parts of the case before trial.
Mangione, who is also facing state murder charges in Utah, appeared in a Brooklyn courtroom where his attorneys laid out arguments challenging the sufficiency of the federal indictment and seeking to suppress certain evidence. Defense motions ahead of trial include claims that elements of the case should be thrown out or limited based on procedural or constitutional grounds.
Prosecutors countered that the charges are supported by credible evidence and that pretrial challenges should not prevent the case from moving forward to a jury. The judge will review filings from both sides and set a timetable for additional hearings and possible rulings.
The federal murder trial is scheduled to begin later this year, and the outcome of the defense motions could shape key aspects of the prosecution’s strategy. Mangione has pleaded not guilty to all counts in the federal indictment, which alleges deliberate and premeditated violence resulting in Thompson’s death.
In addition to the federal proceedings, Mangione still faces a separate state trial, meaning his legal team must coordinate strategies across jurisdictions. The dual criminal process has drawn attention due to the high profile of the victim and the severity of the charges.
At Friday’s hearing, the courtroom was crowded with representatives from both sides as attorneys made their case to the judge. While no rulings were issued immediately, court officials said decisions on major motions could come in the coming weeks, potentially reshaping how the trial unfolds.
As the judge reviews the legal arguments, prosecutors and defense lawyers alike stressed the importance of the pretrial phase in setting the stage for the lengthy and complex litigation ahead.